162 results on '"Chua, Melvin L.K."'
Search Results
2. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population
3. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma
4. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma
5. A universal pipeline to combine spatial transcriptomics, proteomics, and diagnostic H&E assays on a single tissue section to study tissue microenvironment.
6. Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis
7. Effect of tumor-immune microenvironment (TIME) on disparate ascending (A) and descending (D) subtypes of nasopharyngeal carcinoma (NPC).
8. A randomized, multicenter, phase II trial of camrelizumab (Cam) with and without metastasis-directed therapy (MDT) in recurrent/metastatic nasopharyngeal carcinoma (R/M-NPC).
9. Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
10. The prognostic value of deep learning-based percentage of tumour-infiltrating lymphocytes in nasopharyngeal carcinoma.
11. An evaluation of concordance between head and neck advanced practice radiation therapist and radiation oncologists in toxicity assessment for nasopharyngeal carcinoma patients
12. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
13. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
14. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
15. Immunotherapy in Head and Neck Cancer—Ready for Prime Time or More Research Needed?
16. Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer.
17. High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade
18. A Prospective 10-Year Observational Study of Reduction of Radiation Therapy Clinical Target Volume and Dose in Early-Stage Nasopharyngeal Carcinoma
19. Four Influential Clinical Trials in Human Papilloma Virus-Associated Oropharynx Cancer
20. Cluster-Based Radiomics Reveal Spatial Heterogeneity of Bevacizumab Response for Treatment of Radiotherapy-induced Cerebral Necrosis
21. Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia
22. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
23. De-Escalation Strategies in HPV-Associated Oropharynx Cancer—Are we Putting the Cart Before the Horse?
24. Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy
25. Intensity-modulated radiotherapy for paranasal sinuses and base of skull tumors
26. Corrigendum to “Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study” [Eur. J. Radiol. Open 11 (2023) 100529]
27. Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer
28. Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy
29. Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
30. A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis
31. Figure S3 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
32. Supplementary Material from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
33. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
34. Germline DNA damage response (DDR) mutations in an East Asian (EA) cohort with prostate cancer (PCa).
35. Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.
36. ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific
37. Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade
38. Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy
39. Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer
40. Matrix metalloproteinase‐1 facilitates MSC migration via cleavage of IGF‐2/IGFBP2 complex
41. Voxel-based radiomics outlines spatial heterogeneity of cerebral radiation necrosis (RN) associated with bevacizumab (Bev) response in head and neck radiotherapy (RT) patients.
42. Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer
43. A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021
44. Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?
45. Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
46. In Reply to Abbasi et al.
47. Explainable Radiomics Model for the Prediction of Bevacizumab Efficacy in the Treatment of Radiotherapy-Induced Cerebral Necrosis
48. Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck
49. Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
50. Abstract 2258: Germline variants associated with poorer disease prognosis in nasopharyngeal carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.